Beta Bionics (NASDAQ:BBNX) executives used a conference presentation to outline the company’s strategy in insulin delivery, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 1 diabetes who used an automated ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...

Medtronic broadens its diabetes device portfolio with MiniMed Go Smart MDI system launch across Europe The integrated ...

(HealthDay News) — Insulin pump therapy is more effective than multiple daily injections (MDI) for glycemic control in patients with type 2 diabetes, according to a study published online in Diabetes, ...

A large registry study in young people with type 1 diabetes found that hybrid closed-loop systems were linked to slightly better HbA1c and more time in the target glucose range than open-loop pump ...

Use of an insulin pump with a sensor that suspends insulin delivery when blood glucose falls below a set threshold reduced the rate of severe and moderate hypoglycemia among patients with type 1 ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded label for rapid-acting insulin lispro-aabc injection to include administration via ...

An open-source automated insulin delivery (AID) system -- also known as a do-it-yourself system -- was both safe and effective for patients with type 1 diabetes, according to the CREATE trial. Over 24 ...

With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...

All patients said insulin pump therapy helped their diabetes management related to exercise. Older patients with type 1 diabetes (T1D) appear to benefit from insulin pumps and continuous glucose ...

The Insulin Pump Therapy Program continues its treatment for Alberta, Canada citizens with Type 1 Diabetes, says a new development in the case. It will not cease its operations and offers for its ...